CPI-637

Overview

CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC 50 values of 0.03 μM, 0.051 μM and 11.0 μM for CBP , EP300 and BRD4 BD-1 , respectively, and an EC 50 of 0.3 μM for CBP .

Application

Products | Products > Disease Areas > Blood Disease | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Epigenetic Reader Domain | Products > Signaling Pathways > Histone Acetyltransferase

Product Information

• Catalog No.: HY-100482
• CAS No.: 1884712-47-3
• Molecular Formula: C22H22N6O
• Molecular Weight: 386.45
• Purity: 99.87%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 0.96 mg/mL (2.48 mM); Clear solution
• Availability: In-stock

Source

Original product source